Michael Posternak, MD.Dr. Posternak has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
The study is not without flaws, but it raises some concerns about the long term health-effects of antipsychotic augmentation.
Viibryd has gone generic, but is it worth prescribing? We review all there is to know about vilazodone in this update from our #1 most read article of 2023.